# Sequential Optimization of Dose and Schedule of PfSPZ Vaccine

> **NCT02704533** · PHASE1 · COMPLETED · sponsor: **Sanaria Inc.** · enrollment: 45 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** PfSPZ Vaccine
- **BIOLOGICAL:** PfSPZ Challenge (NF54)
- **BIOLOGICAL:** PfSPZ Challenge (7G8)
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT02704533
- **Lead sponsor:** Sanaria Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-29
- **Primary completion:** 2018-10-19
- **Final completion:** 2018-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-02-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704533, "Sequential Optimization of Dose and Schedule of PfSPZ Vaccine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02704533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*